SCHEMBL3596680

SCHEMBL3596680

CCNC(=O)OC/C=C/c1c(C)nn(C)c1Oc1cc(O[C@@H](C)C(=O)O)c(Cl)cc1Cl

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.34
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33
HSD17B10 Q99714 2/20 0.33
HPGD P15428 1/20 0.32
GPBAR1 Q8TDU6 5/20 0.32
SHMT2 P34897 1/20 0.31
PPARG P37231 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
TSHR P16473 1/20 0.30
HTR2A P28223 1/20 0.30
HTR2C P28335 1/20 0.30
HTR2B P41595 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3596688 1.00 SMN1; SMN2 (0.34) SMN1; SMN2ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL3612153 0.90 POLB (0.34) ALDH1A1KDM4EHSD17B10HPGDGPBAR1
SCHEMBL3612147 0.90 POLB (0.34) ALDH1A1KDM4EHSD17B10HPGDGPBAR1
SCHEMBL3604694 0.88 ALDH1A1 (0.33) SMN1; SMN2ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL3604697 0.88 ALDH1A1 (0.33) SMN1; SMN2ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL3607759 0.85 L3MBTL1 (0.37) SMN1; SMN2ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL3607755 0.85 L3MBTL1 (0.37) SMN1; SMN2ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL3610167 0.85 KDM4E (0.36) SMN1; SMN2ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL3610174 0.85 KDM4E (0.36) SMN1; SMN2ALDH1A1KDM4EHSD17B10HPGD
SCHEMBL3604701 0.84 KDM4E (0.36) SMN1; SMN2ALDH1A1KDM4EHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100076005-A1 ISOCARBOSTYRIL ALKALOID DERIVATIVES HAVING ANTI-PROLIFERATIVE AND ANTI-MIGRATORY ACTIVITIES UNIBIOSCREEN SA (BE) 2010-03-25 US disclosed
US-20100016396-A1 PYRAZOLE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-01-21 US disclosed
EP-2128138-A1 PYRAZOLE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2009-12-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100076005-A1 ISOCARBOSTYRIL ALKALOID DERIVATIVES HAVING ANTI-PROLIFERATIVE AND ANTI-MIGRATORY ACTIVITIES MIF, IMPDH1, IMPDH2 SMN1; SMN2 714/4885ALDH1A1 445/4885KDM4E 3503/4885
US-20100016396-A1 PYRAZOLE COMPOUND SLC5A1, SLC5A2, GLP1R SMN1; SMN2 4515/4885ALDH1A1 365/4885KDM4E 2049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.